MedTrace Logo

AZD8566 Food Effect/Microtracer Study

NCT00866385 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 21

Last updated 2009-06-09

No results posted yet for this study

Summary

A study designed to look at how the drug AZD8566 is taken up by the body when given with or without food. In some subjects a comparison will be made with a very small labelled microdose given into a vein.

Conditions

  • Healthy Volunteer Study

Interventions

DRUG

AZD8566

Single 6 mg oral solution dose

DRUG

AZD8566 IV carbon labelled

Single 10 mcg intravenous carbon-14 microtracer dose

Sponsors & Collaborators

Principal Investigators

  • Jo Collier, Dr,MB, ChB · Pharmaceutical Profiles, Mere Way, Ruddington Fields, Nottingham NG11 6JS

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-03-31
Primary Completion
2009-03-31
Completion
2009-04-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00866385 on ClinicalTrials.gov